Resource Library

Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa

This study compares the effectiveness and cost-effectiveness of providing antiretroviral therapy vs PrEP in South Africa

Financing & Costing

Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa

This study estimates the cost-effectiveness of daily oral PrEP, with a protective effect against the herpes simplex virus as well as HIV, among HIV serodifferent couples in South Africa

Financing & Costing

FDA approves first drug for reducing the risk of sexually acquired HIV infection

This article from July 16, 2012 announces the U.S. Food and Drug Administration's approval of Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners.

Normative Guidance/Policies

From Proof-of-Concept to Prevention Phenomenon in Five Years

This timeline, first appearing in AVAC Report 2014/15: HIV Prevention on the Line, shows PrEP going from proof-of-concept to prevention phenomenon in five years and can be used to anticipate and speed action on the next generation of ARV-based prevention options.

Research

Oral PrEP Training for Providers

This modifiable training slide deck was developed with support from USAID and PEPFAR through the Meeting Targets and Maintaining Epidemic Control (EpiC) project. The materials reflect WHO guidance as of 4 April 2022 and build on lessons learned from nearly ten years of oral PrEP implementation. The training is built so that it can be…

Service Delivery

OPTIONS Knowledge, Attitude and Practice Literature Review and Survey Analysis

This literature review looks at completed and ongoing studies that include knowledge, attitude and practice (KAP) surveys in sub-Saharan Africa of providers and potential providers of oral preexposure prophylaxis (PrEP) to adolescent girls and young women (AGYW).

Research, Service Delivery

Health Care Workers’ Knowledge, Attitudes, and Practices Related to Oral PrEP Provision to Adolescent Girls and Young Women in Zimbabwe

This poster describes the results of a cross-sectional qualitative study, interviewing providers at public, private, and nongovernmental health facilities in Zimbabwe offering PrEP to explore providers’ attitudes toward and experiences delivering PrEP to AGYW.

Research, Service Delivery

Presentation

Understanding Service Providers’ Knowledge of Oral PrEP and Attitudes Toward Provisionto Populations at Substantial HIV Risk in South Africa

This poster describes the results of a cross-sectional qualitative study, interviewing providers at public, private, and nongovernmental health facilities in South Africa offering PrEP to explore providers’ attitudes toward and experiences delivering PrEP to AGYW.

Research, Service Delivery

#GarawaPrEPa Campaign from Chitungwiza, Zimbabwe

Pangaea Zimbabwe AIDS Trust (PZAT), an implementing partner in the USAID- and PEPFAR-funded OPTIONS Consortium, used the PrEP Communications Accelerator to develop a PrEP demand creation campaign targeting AGYW in Chitungwiza, Zimbabwe. To learn more about this campaign, see this campaign photo story. Print Materials Flyer Poster (friends) Poster (family) Poster (peace) Poster (shades) Poster…

Community/Advocacy, Demand Creation/Marketing